Latest data from October 8, 2021
Number of Health Center respondents = 6 (86% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 4,008 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 95.39% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 350 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 97.43% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 4.47% | 2.57% |
| White, Hispanic/Latino Patients | 0.05% | 0.00% |
| Black/African American, Non-Hispanic/Latino Patients | 4.44% | 2.86% |
| Black/African American, Hispanic/Latino Patients | 1.00% | 0.86% |
| Asian Patients3 | 18.89% | 22.86% |
| American Indian/Alaska Native Patients3 | 0.05% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 66.34% | 69.43% |
| Patients with More than one race3 | 1.50% | 1.43% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.17% | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 2.37% | 0.00% |
| Unreported/Refused to Report Race and Ethnicity | 0.72% | 0.00% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 760 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 99.10% |
| COVID-19 Immunization Series Completed | 2,137 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 98.08% |
| COVID-19 Immunization Series Additional | 138 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 95.62% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 0.26% | 0.47% | 4.35% |
| White, Hispanic/Latino Patients | 0.00% | 0.05% | 0.00% |
| Black/African American, Non-Hispanic/Latino Patients | 1.58% | 0.80% | 1.45% |
| Black/African American, Hispanic/Latino Patients | 0.13% | 0.37% | 0.00% |
| Asian Patients3 | 2.11% | 1.68% | 26.81% |
| American Indian/Alaska Native Patients3 | 0.00% | 0.00% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 24.74% | 20.64% | 63.04% |
| Patients with More than one race3 | 0.13% | 0.37% | 3.62% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.26% | 0.00% | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.13% | 0.00% | 0.00% |
| Unreported/Refused to Report Race and Ethnicity | 70.66% | 75.62% | 0.72% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 50.00% |
| 1 to 24 Hours | 0.00% |
| More Than 24 Hours | 33.33% |
| N/A | 16.67% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 16.67% |
| Staffing to administer the vaccine | 50.00% |
| Vaccine confidence | 0.00% |
| Vaccine storage capacity | 16.67% |
| Vaccine supply | 33.33% |
| Other | 0.00% |
| None | 33.33% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 16.67% |
| Average Percent of Health Center Visits Conducted Virtually | 8.33% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 50.00% |
| Number of Mobile Van Sites | 7 |
| Number of Pop-up Clinics | 5 |
| Number of School-Based Vaccination Sites | 0 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 16.67% |
| Refer patients to another organization that provides monoclonal antibody therapies | 16.67% |
| None | 66.67% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 16.67% |
| Patient awareness/education | 16.67% |
| Staffing capacity | 33.33% |
| Therapy administration/onsite logistics | 33.33% |
| Other | 33.33% |
| None | 33.33% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
